Tissue-specific p53 expression in the nervous system

Molecular Brain Research

Volumn 72, Issue 1, 1999, Pages 40-46

  Tendler, Yevgeny ^a   Weisinger, Gary ^b   Coleman, Raymond ^c   Diamond, Eric ^a   Lischinsky, Sophie ^a   Kerner, Hedviga ^e   Rotter, Varda ^d   Zinder, Oren ^a,c  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e Technion Israel Inst of Technology ^*

Author keywords

CNS; p53; PNS; Transgenic mice

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; PROTEIN P53;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CORNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MOUSE; NERVOUS SYSTEM; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PONS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PURKINJE CELL; RETINA; THALAMUS; TISSUE SPECIFICITY; TRANSGENIC MOUSE;

ABNORMALITIES; ANIMALS; BRAIN; CHLORAMPHENICOL O-ACETYLTRANSFERASE; EYE PROTEINS; FOOD HABITS; GENE EXPRESSION REGULATION; GENES, P53; GENES, REPORTER; GROWTH DISORDERS; MALE; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NERVOUS SYSTEM; ORGAN SPECIFICITY; PHENOTYPE; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; SPINAL CORD; TESTIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032828720     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00202-8     Document Type: Article

References (39)

1. Agoff S.N., Hou J., Linzer D.I.M., Wu B. Regulation of the human NSP 70 promoter by p53. Science (Washington DC). 259:1993;84-87.
2. Almon E., Goldfinger N., Kapon A., Schwartz D., Levine A.J., Rotter V. Testicular tissue-specific expression of the p53 suppressor gene. Dev. Biol. 157:1993;107-116.
3. Bi W., Wu L., Coustry F., de Crombrugghe B., Maity S.N. DNA binding specificity of the CCAAT-binding factor CBR/NF-Y. J. Biol. Chem. 272:1997;26562-26572.
4. Borellini F., Glazer R.I. Induction of SP-1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erytholeukemia cell line TF-1. J. Biol. Chem. 268:1993;7923-7928.
5. Chin D.Y., Chumakov A.M., Park D.Y., Silla A.G., Koefler H.P. Modulation of m-RNA expression of a novel human myeloid selective CCAAT/enhancer binding protein gene (C/EBP epsilon). Blood. 90:1997;2987-2994.
6. Eizenberg O., Faber-Elman A., Gottlieb E., Oren M., Rotter V., Schwartz M. p53 plays a regulatory role in differentiation and apoptosis of central nervous system associated cell. Molecular and Cellular Biology. 16:1996;5178-5185.
7. Eizenberg O., Farber-Elman A., Gottlieb E., Oren M., Rotter V., Schwartz M. Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J. 14:1995;1136-1144.
8. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF-1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
9. Fields S., Jang S.K. Presence of potent transcription activating sequences in the p53 protein. Science. 249:1990;1046-1049.
10. Hall P.A., Philip M., McKee P.H., Menage H.P., Dover R., Lane D.P. High levels of p53 protein in UV-irradiated normal human skin. Oncogene. 8:1993;203-207.
11. Harlow E., Crawford L.V., Pim D.C., Williamson N.M. Monoclonal antibodies specific for simian virus 40 antigens. J. Virol. 39:1981;861-869.
12. Jiang Y., Armstrong D., Albrecht U., Atkins C.M., Noebeles J.L., Eichele G., Sweatt J.D., Beaudet A.L. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 21:1998;799-811.
13. Jordan J., Galindo M.F., Weichselbaum R.R., Beckett M., Ghadge G.D., Roos R.P., Leiden J.M., Miller R.J. p53 expression induces apoptosis in hippocampal pyramidal neuron cultures. J. Neurosci. 17:1997;1397-1405.
14. Kastan M.B., Zhan Q., El-Deiry W.S., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., Fornace A.J. A mammalian cell cycle checkpoint utilizing p53 and GADD-45 is defective in ataxia-telagiectasia. Cell. 71:1992;587-597.
15. Kaufman M.H., Kaufman D.B., Brune R.M., Stark M., Armstrong J.F., Clarke A.R. Analysis of fused maxillary incisor dentition in p53-deficient exencephalic mice. J. Anat. 191:1997;57-64.
16. Kern S.E., Kinzler K.W., Bruscin A., Jarosz D., Friedman P., Vogelstein B. Identification of p53 as a sequence-specific DNA-binding. Science. 252:1991;1708-1710.
17. Kuerbit S.J., Plunkett B.S., Walsh W.V., Kastan M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7491-7495.
18. Kukushkin A.N., Svetlikova S.B., Belov D.N., Slepneva N.I., Pospelov V.A. Transcription Factors C/EBP and AP-1 modulate promoter activity of human p53 regulatory region. Molecular Biology. 30:1996;56-62.
19. LaGamma E.F., Weisinger G., Lenn N.J., Strecker R.E. Genetically modified primary astrocytes as cellular vehicles for gene therapy in the brain. Cell Transplantation. 2:1993;207-214.
20. Lin X., Miller C.W., Koeffler P.H., Berk A.Y. The p53 activation domain binds the TATA box binding polypeptide in holo-TFIID and a neighbouring p53 domain inhibits transcription. Mol. Cell. Biol. 13:1993;3291-3300.
21. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
22. Lu X., Lane D.P. Specific repression of TATA mediated but not initiator-mediated transcription by wild type p53. Cell. 75:1993;765-778.
23. Mann S.S., Hammarback J.A. Gene localization and developmental expression of light microtubule-associated protein 1A (MAP1A) and MAP1B. J. Neurosci. Res. 43:1996;535-544.
24. McCaffery P., Mey J., Drager U.C. Light-mediated retinoic acid production. Proc. Natl. Acad. Sci. U.S.A. 93:1996;12570-12574.
25. Mock D.H., Vartikar J., Laiminis L.A. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosomal instability syndromes. Nature (London). 363:1993;281-283.
26. Morosetti R., Park D.J., Chumakov A.M., Grillier I., Shiohara M., Gombart A.F., Nakamaki T., Weinberg K., Koeffler H.P. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. Blood. 90:1997;2591-2600.
27. Ronen D., Rotter V., Reisman D. Expression from murine p53 promoter is mediated by factor-binding to a downstream helix-loop-helix recognition motif. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4128-4132.
28. Sadoul R., Quiquerez A.-L., Martinou I., Fernandez P.A., Martinou J.-C. p53 protein in sympathetic neurons: cytoplasmic localization and no apparent function in apoptosis. J. Neurosci. Res. 43:1996;594-601.
29. Sah V.P., Attardi L.D., Mulligan G.J., Williams B.O., Bronson R.T., Jacks T. A subset of p53-deficient embryos exhibit exencephaly. Nature Genetics. 10:1995;175-180.
30. Sakhi S., Bruce A., Sun N., Tocco G., Baudry M., Schreiber S.S. P53 induction is associated with neuronal damage in the Central Nervous System. Proc. Natl. Acad. Sci. U.S.A. 91:1994;7525-7529.
31. Seto E., Usheva A., Zambetti G.P., Momand J., Horikoshi N., Weinmann R., Levine A.J., Glazer R.I. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. U.S.A. 89:1992;12028-12032.
32. Shaulsky G., Goldfinger N., Peled A., Rotter V. Invovement of wild-type p53 in pre-B-cell differentiation, in vitro. Proc. Natl. Acad. Sci. U.S.A. 88:1991;8982-8986.
33. Temple S., Raff M.C. Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions. Cell. 44:1986;773-779.
34. Tishler R.B., Caldewood S.K., Coleman C.N., Price B.D. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 53:1993;2212-2216.
35. Wood K.A., Youle R.J. The role of free radicals and p53 in neuron apoptosis in vivo. J. Neurosci. 15:1995;5851-5857.
36. Wu X., Bayle J.H., Olson D., Levin A.J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1993;1126-1132.
37. Xiang H., Hochman D.W., Saya H., Fujiwara T., Schwartzkroin P.A., Morrison R.S. Evidence for p53-mediated modulation of neuronal viability. J. Neurosci. 16:1996;6753-6765.
38. Zhan Q., Carrier, Fornace A.J. Jr. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol. 13:1993;4242-4250.
39. Zhan Q., Fan S., Bae I., Guillouf C., Liebermann D.A., O'Connor P.M., Fornace A.J. Jr. Induction of bax by genotoxic stress in human cell correlates with normal p53 status and apoptosis. Oncogene. 9:1994;3743-3751.